Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients ; volume:13 ; number:3 ; day:10 ; month:6 ; year:2011 ; pages:1-11 ; date:6.2011
Breast cancer research ; 13, Heft 3 (10.6.2011), 1-11, 6.2011
- Urheber
-
Kallergi, Galatea
- Beteiligte Personen und Organisationen
-
Papadaki, Maria A.
Politaki, Eleni
Mavroudis, Dimitris
Georgoulias, Vassilis
Agelaki, Sophia
SpringerLink (Online service)
- DOI
-
10.1186/bcr2896
- URN
-
urn:nbn:de:1111-2016032411999
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kallergi, Galatea
- Papadaki, Maria A.
- Politaki, Eleni
- Mavroudis, Dimitris
- Georgoulias, Vassilis
- Agelaki, Sophia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
Biomarkers in cancer/Circulating tumour markers
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage
Circulating Tumour DNA in Melanoma—Clinic Ready?
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
Biomarkers in cancer/Circulating tumour markers
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage
Circulating Tumour DNA in Melanoma—Clinic Ready?
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
Biomarkers in cancer/Circulating tumour markers
Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage
Circulating Tumour DNA in Melanoma—Clinic Ready?